Hepatitis C and Drug User Health Preceptorship
What does Preceptorship program include?
The goal of the Hepatitis C and Drug User Health Preceptorship program is for participants to build their capacity to provide HCV treatment and comprehensive, stigma-free drug user health services. This clinical training program includes 5 hours of didactic learning taught by content experts (CME provided) and 8 hours of on-site experiential learning at innovative practices providing integrated hepatitis C treatment and drug user health throughout NYS.
Learning Objectives:After completing the preceptorship program, participants will be able to:
- Conduct hepatitis C pre-treatment evaluation, medication regimen selection, on-treatment monitoring and post-treatment follow-up.
- Employ innovative strategies in opioid use disorder care and office-based buprenorphine treatment.
- Synthesize approaches to integrating hepatitis C and buprenorphine treatment in the same care setting.
- Integrate harm reduction principles into the care of people who use drugs.
Who is eligible to participate in the Hepatitis C and Drug User Health Preceptorship?
NYS clinical professionals (MDs, DOs, NPs, PAs)
For More Information Contact:
Participation in the Hepatitis C and Drug User Health Preceptorship program includes an application process. To learn more, please contact: Emily Scognamiglio, MPH email: Emily.Scognamiglio@mountsinai.org.